-
CQDM, Healthy Brains for Healthy Lives (HBHL), Corbin Therapeutics and Brain Canada award $1.5 million to McGill Professor Philippe Gros who will pursue the development of new molecules to fight neuroinflammation
https://braincanada.ca/about/news-updates/cqdm-healthy-brains-for-healthy-lives-hbhl-corbin-therapeutics-and-brain-canada-award-1-5-million-to-mcgill-professor-philippe-gros-who-will-pursue-the-development-of-new-molecules-to-fight-neuroinflammationMontreal, May 2nd, 2019 – CQDM is pleased to announce that Professor Philippe Gros from McGill University has been awarded $1.5 million as part of the SynergiQC program to pursue the development and validation of new inhibitors of ubiquitin-specific protein protease (USP-15) and its partner TRIM25,...
-
Creating computers that work like the human brain
https://braincanada.ca/about/news-updates/creating-computers-that-work-like-the-human-brainLearning in Machines and Brains Senior Fellow, Joëlle Pineau, presents at the December 2015 meeting of CIFAR’s program Learning in Machines and Brains Learning in Machines and Brains is one of the 14 global research programs at CIFAR (Canadian Institute For Advanced Research). The CIFAR research...
-
Creating viruses that can shrink brain tumours
https://braincanada.ca/about/news-updates/creating-viruses-that-can-shrink-brain-tumoursBright flashes of green and yellow mark the spots where Farmington virus is killing susceptible target cells (red). David Stojdl and his team are trying a different way to treat brain tumours. Their lab has custom-built an oncolytic virus biotherapy specifically for the treatment of the devastating...
-
CRF receptor-mediated sensitization of 5-HT2A receptor signalling
https://braincanada.ca/funded-grants/crf-receptor-mediated-sensitization-of-5-ht2a-receptor-signallingThe proposed research in this application will significantly broaden our understanding of the molecular basis for how stress leads to anxiety and depression. Project Overview The proposed research in this application will significantly broaden our understanding of the molecular basis for how stress...
-
CRISPR/Cas9-Mediated Gene Therapy to Correct Aniridia in a Mouse Model
https://braincanada.ca/funded-grants/crispr-cas9-mediated-gene-therapy-to-correct-aniridia-in-a-mouse-modelMs. Zeinab Mohanna’s research will test the hypothesis that CRISPR/Cas9-mediated genome editing can increase the expression of PAX6 protein, improve the function of the neural and other tissues of the eye, and ultimately rescue the mutant phenotype in the mouse model of aniridia. Project...
-
Critical new funding for dementia project
https://braincanada.ca/about/news-updates/critical-new-funding-for-dementia-projectScientist from Sunnybrook Research Institute and his multinational team receive a funding boost from WBHI, CIHR, and Brain Canada Women’s Brain Health Initiative (WBHI), Canadian Institutes of Health Research (CIHR), and Brain Canada are pleased to announce that Dr. Mario Masellis has been selected...
-
Crosstalk between immune response and metabolic signaling: targeting leptin/AMPK axis to restore metabolic homeostasis in ALS
https://braincanada.ca/funded-grants/crosstalk-between-immune-response-and-metabolic-signaling-targeting-leptin-ampk-axis-to-restore-metabolic-homeostasis-in-alsIncreased metabolism (hypermetabolism) is a characteristic often associated with more aggressive, faster progressing cases of ALS. Project Overview Increased metabolism (hypermetabolism) is a characteristic often associated with more aggressive, faster progressing cases of ALS. Recently, after...
-
CRS Doctoral Research Awards and Operating Grants
https://braincanada.ca/about/news-updates/crs-doctoral-research-awards-and-operating-grantsBrain Canada is pleased to announce that, in partnership with the Cancer Research Society (CRS), will fund four outstanding research projects focused on brain cancer As part of the of 2025 Doctoral Research Awards and 2025 Operating Grants. Brain Canada is pleased to announce that, in partnership...
-
CSF constitutents as mediators of brain damage in demyelinating diseases of the central nervous system
https://braincanada.ca/funded-grants/csf-constitutents-as-mediators-of-brain-damage-in-demyelinating-diseases-of-the-central-nervous-systemMost nerves in the brain are surrounded by myelin, an insulating cover that allows them communicate efficiently. Project Overview Most nerves in the brain are surrounded by myelin, an insulating cover that allows them communicate efficiently. Brain damage in multiple sclerosis (MS) results from...
-
CSF constitutents as mediators of brain damage in demyelinating diseases of the central nervous system
https://braincanada.ca/funded-grants/csf-constitutents-as-mediators-of-brain-damage-in-demyelinating-diseases-of-the-central-nervous-system-2Most nerves in the brain are surrounded by myelin, an insulating cover that allows them communicate efficiently. Project Overview Most nerves in the brain are surrounded by myelin, an insulating cover that allows them communicate efficiently. Brain damage in multiple sclerosis (MS) results from...